Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A401UY | ISIN: US36151G6008 | Ticker-Symbol: 12Q0
Lang & Schwarz
27.04.24
13:02 Uhr
3,870 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTELLIGENT BIO SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
INTELLIGENT BIO SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
3,8103,93027.04.
0,0000,00026.04.

Aktuelle News zur INTELLIGENT BIO SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.04.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report3
18.04.Intelligent Bio Solutions reports Preliminary Unaudited Fiscal Q3 results2
18.04.Intelligent Bio Solutions expects approximate unaudited Q3 revenue of $0.82M3
18.04.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results406NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
11.04.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader6
09.04.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report5
05.04.Looking Into Intelligent Bio Solutions' Recent Short Interest2
26.03.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC9
13.03.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules10
11.03.Intelligent BIO Ekes up on Private Placement8
11.03.Intelligent Bio Solutions Announces $10.1 Mln Private Placement2
11.03.Intelligent Bio Solutions secures $10.1 million in private placement4
11.03.Intelligent Bio Solutions announces $10M private placement priced at-the-market under Nasdaq rules2
11.03.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules1
06.03.Peering Into Intelligent Bio Solutions' Recent Short Interest9
01.03.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 202415
29.02.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report7
28.02.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway358NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing...
► Artikel lesen
20.02.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report16
19.02.Peering Into Intelligent Bio Solutions' Recent Short Interest8
Seite:  Weiter >>
63 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,10